Duncan Bucknell

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: US: Supreme Court hears oral...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. Highlights this week included: Federal Circuit affirms invalidity of Teva’s...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: EU: CJEU guidance on Article...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Australia: APO: Hospital and doctor...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Codiovan (Valsartan / Hydrochlorothiazide) –...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: UK Supreme Court: Industrial application...

  Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: WIPO Re:Search bridges public,...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: CJEU rules no patent protection...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: EU: No more patents for...

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Indian generics Aurobindo Pharma Limited...